CHEMFAB ALKALIS Latest Share Price (CHEMFAB)
TODAY IN ONE LINE
CHEMFAB rose 1.4% on above-average volume (519569.9x avg), in line with Nifty's 1.3% move.
With a market cap of ₹475.77 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
CHEMFAB ALKALIS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 24.7% over 1Y
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Promoter SellingPromoter holding decreased by 21.94% QoQ
- ●Rising Receivables vs SalesReceivables grew 16.3% outpacing sales growth of 2.2%
Latest CHEMFAB ALKALIS News
What changed recently?
Recent events, corporate actions, and announcements.
CHEMFAB ALKALIS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for CHEMFAB ALKALIS, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
CHEMFAB ALKALIS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for CHEMFAB ALKALIS — derived from the latest tape, not yesterday's close.
CHEMFAB ALKALIS last traded at ₹332.3 with an intraday range of ₹316.8–₹351.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹332.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 420.47 | +88.17 | +26.53% |
| R3 | 385.47 | +53.17 | +16.00% |
| R2 | 368.63 | +36.33 | +10.93% |
| R1 | 350.47 | +18.17 | +5.47% |
| PIVOT | 333.63 | 1.33 | 0.40% |
| CURRENT | 332.30 | — | — |
| S1 | 315.47 | -16.83 | -5.07% |
| S2 | 298.63 | -33.67 | -10.13% |
| S3 | 280.47 | -51.83 | -15.60% |
| S4 | 245.47 | -86.83 | -26.13% |
CHEMFAB is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹316.8–₹325
Trading Inside opening range
CHEMFAB ALKALIS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for CHEMFAB ALKALIS — consolidated or standalone — with margins, YoY growth and key ratios inline.
CHEMFAB ALKALIS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹475.77 Cr. and reported EPS of ₹3.99.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 311 | 311 ▲ 0.0% |
| Sales Growth YoY %Derived | -6.98% | -6.98% |
| Other Income | 9 | 9 ▲ 0.0% |
| Total Income | 320 | 320 ▲ 0.0% |
| 103 | 103 ▲ 0.0% | |
| Gross ProfitDerived | 208 | 208 ▲ 0.0% |
| Gross Margin %Derived | 66.89% | 66.89% |
| 181 | 181 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 27 | 27 ▲ 0.0% |
| OPM %Derived | 8.75% | 8.75% |
| 36 | 36 ▲ 0.0% | |
| Profit Before Tax (PBT) | -0 | -0 ▲ 0.0% |
| 3 | 3 ▲ 0.0% | |
| Effective Tax %Derived | -1,613.25% | -1,613.25% |
| Total Profit for Period | -3 | -3 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | -3 | -3 ▲ 0.0% |
| Net Profit Margin %Derived | -1.10% | -1.10% |
| PAT Growth YoY %Derived | 50.63% | 50.63% |
| Earnings Per Share (EPS ₹) | -2.38 | -2.38 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 1 | 1 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 320 | 320 ▲ 0.0% |
| Material Cost % of RevenueDerived | 30.55% | 30.55% |
| Employee Cost % of RevenueDerived | 8.46% | 8.46% |
| Other Cost % of RevenueDerived | 49.68% | 49.68% |
| Interest Coverage (x)Derived | -0.16x | -0.16x |
| Period | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 205 | 205 ▲ 0.0% | 181 ▼ 11.6% | 181 ▲ 0.0% | 272 ▲ 50.2% | 272 ▲ 0.0% | 331 ▲ 22.0% | 331 ▲ 0.0% | 327 ▼ 1.2% | 327 ▲ 0.0% | 334 ▲ 2.2% | 334 ▲ 0.0% | 311 ▼ 7.0% | 311 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | -11.59% | — | 50.21% | 50.21% | 22.01% | 22.01% | -1.23% | -1.23% | 2.16% | 2.16% | -6.98% | -6.98% | |
| Other Income | 3 | 3 ▲ 0.0% | 1 ▼ 54.5% | 1 ▲ 0.0% | 6 ▲ 302.9% | 6 ▲ 0.0% | 6 ▼ 3.1% | 6 ▲ 0.0% | 9 ▲ 54.6% | 9 ▲ 0.0% | 7 ▼ 16.7% | 7 ▲ 0.0% | 9 ▲ 22.1% | 9 ▲ 0.0% | |
| Total Income | 208 | 208 ▲ 0.0% | 182 ▼ 12.2% | 182 ▲ 0.0% | 277 ▲ 52.2% | 277 ▲ 0.0% | 337 ▲ 21.5% | 337 ▲ 0.0% | 336 ▼ 0.3% | 336 ▲ 0.0% | 341 ▲ 1.7% | 341 ▲ 0.0% | 320 ▼ 6.4% | 320 ▲ 0.0% | |
37 | 37 ▲ 0.0% | 43 ▲ 16.7% | 43 ▲ 0.0% | 80 ▲ 86.8% | 80 ▲ 0.0% | 70 ▼ 13.3% | 70 ▲ 0.0% | 98 ▲ 40.9% | 98 ▲ 0.0% | 100 ▲ 1.5% | 100 ▲ 0.0% | 103 ▲ 3.3% | 103 ▲ 0.0% | ||
| Gross ProfitDerived | 168 | 168 ▲ 0.0% | 138 ▼ 17.8% | 138 ▲ 0.0% | 191 ▲ 38.8% | 191 ▲ 0.0% | 262 ▲ 36.9% | 262 ▲ 0.0% | 229 ▼ 12.4% | 229 ▲ 0.0% | 235 ▲ 2.4% | 235 ▲ 0.0% | 208 ▼ 11.4% | 208 ▲ 0.0% | |
| Gross Margin %Derived | 81.96% | 81.96% | 76.19% | 76.19% | 70.40% | 70.40% | 78.97% | 78.97% | 70.01% | 70.01% | 70.20% | 70.20% | 66.89% | 66.89% | |
113 | 113 ▲ 0.0% | 114 ▲ 1.7% | 114 ▲ 0.0% | 135 ▲ 17.5% | 135 ▲ 0.0% | 151 ▲ 12.4% | 151 ▲ 0.0% | 175 ▲ 15.9% | 175 ▲ 0.0% | 191 ▲ 9.0% | 191 ▲ 0.0% | 181 ▼ 5.3% | 181 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 55 | 55 ▲ 0.0% | 23 ▼ 57.7% | 23 ▲ 0.0% | 57 ▲ 143.2% | 57 ▲ 0.0% | 110 ▲ 95.1% | 110 ▲ 0.0% | 54 ▼ 51.2% | 54 ▲ 0.0% | 44 ▼ 18.9% | 44 ▲ 0.0% | 27 ▼ 37.7% | 27 ▲ 0.0% | |
| OPM %Derived | 26.91% | 26.91% | 12.88% | 12.88% | 20.85% | 20.85% | 33.34% | 33.34% | 16.47% | 16.47% | 13.08% | 13.08% | 8.75% | 8.75% | |
25 | 25 ▲ 0.0% | 23 ▼ 9.4% | 23 ▲ 0.0% | 23 ▲ 2.5% | 23 ▲ 0.0% | 20 ▼ 14.8% | 20 ▲ 0.0% | 23 ▲ 17.7% | 23 ▲ 0.0% | 31 ▲ 34.7% | 31 ▲ 0.0% | 36 ▲ 15.1% | 36 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 27 | 27 ▲ 0.0% | 2 ▼ 92.4% | 2 ▲ 0.0% | 39 ▲ 1830.2% | 39 ▲ 0.0% | 89 ▲ 128.7% | 89 ▲ 0.0% | 39 ▼ 56.2% | 39 ▲ 0.0% | -0 ▼ 100.8% | -0 ▲ 0.0% | -0 ▲ 34.5% | -0 ▲ 0.0% | |
1 | 1 ▲ 0.0% | 10 ▲ 702.4% | 10 ▲ 0.0% | 10 ▲ 1.9% | 10 ▲ 0.0% | 25 ▲ 140.0% | 25 ▲ 0.0% | 13 ▼ 48.4% | 13 ▲ 0.0% | 7 ▼ 48.3% | 7 ▲ 0.0% | 3 ▼ 51.4% | 3 ▲ 0.0% | ||
| Effective Tax %Derived | 4.74% | 4.74% | 501.40% | 501.40% | 26.48% | 26.48% | 27.79% | 27.79% | 32.76% | 32.76% | -2,172.53% | -2,172.53% | -1,613.25% | -1,613.25% | |
| Total Profit for Period | 25 | 25 ▲ 0.0% | -8 ▼ 132.0% | -8 ▲ 0.0% | 29 ▲ 453.5% | 29 ▲ 0.0% | 65 ▲ 124.7% | 65 ▲ 0.0% | 26 ▼ 59.2% | 26 ▲ 0.0% | -7 ▼ 126.4% | -7 ▲ 0.0% | -3 ▲ 50.6% | -3 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 25 | 25 ▲ 0.0% | -8 ▼ 132.0% | -8 ▲ 0.0% | 29 ▲ 453.5% | 29 ▲ 0.0% | 65 ▲ 124.7% | 65 ▲ 0.0% | 26 ▼ 59.2% | 26 ▲ 0.0% | -7 ▼ 126.4% | -7 ▲ 0.0% | -3 ▲ 50.6% | -3 ▲ 0.0% | |
| Net Profit Margin %Derived | 12.44% | 12.44% | -4.50% | -4.50% | 10.58% | 10.58% | 19.49% | 19.49% | 8.04% | 8.04% | -2.08% | -2.08% | -1.10% | -1.10% | |
| PAT Growth YoY %Derived | — | — | -131.96% | — | 453.52% | 453.52% | 124.66% | 124.66% | -59.24% | -59.24% | -126.37% | -126.37% | 50.63% | 50.63% | |
| Earnings Per Share (EPS ₹) | 18.26 | 18.26 ▲ 0.0% | -5.78 ▼ 131.7% | -5.78 ▲ 0.0% | 20.34 ▲ 451.9% | 20.34 ▲ 0.0% | 45.54 ▲ 123.9% | 45.54 ▲ 0.0% | 18.50 ▼ 59.4% | 18.50 ▲ 0.0% | -4.83 ▼ 126.1% | -4.83 ▲ 0.0% | -2.38 ▲ 50.7% | -2.38 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.9% | 1 ▲ 0.0% | 1 ▲ 0.5% | 1 ▲ 0.0% | 1 ▲ 0.3% | 1 ▲ 0.0% | 1 ▲ 0.3% | 1 ▲ 0.0% | 1 ▲ 1.0% | 1 ▲ 0.0% | 1 ▲ 0.1% | 1 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 1 | 1 ▲ 0.0% | 1 ▼ 25.0% | 1 ▲ 0.0% | 0 ▼ 14.9% | 0 ▲ 0.0% | -1 ▼ 240.7% | -1 ▲ 0.0% | 0 ▲ 134.1% | 0 ▲ 0.0% | 0 ▲ 75.2% | 0 ▲ 0.0% | 1 ▲ 53.7% | 1 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 181 | 181 ▲ 0.0% | 180 ▼ 0.4% | 180 ▲ 0.0% | 238 ▲ 32.2% | 238 ▲ 0.0% | 247 ▲ 3.9% | 247 ▲ 0.0% | 297 ▲ 19.9% | 297 ▲ 0.0% | 342 ▲ 15.2% | 342 ▲ 0.0% | 320 ▼ 6.4% | 320 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 15.40% | 15.40% | 14.02% | 14.02% | 17.99% | 17.99% | 14.61% | 14.61% | 22.50% | 22.50% | 30.54% | 30.54% | 30.55% | 30.55% | |
| Employee Cost % of RevenueDerived | 8.84% | 8.84% | 10.15% | 10.15% | 7.25% | 7.25% | 5.83% | 5.83% | 7.14% | 7.14% | 7.63% | 7.63% | 8.46% | 8.46% | |
| Other Cost % of RevenueDerived | 46.21% | 46.21% | 53.17% | 53.17% | 42.30% | 42.30% | 39.81% | 39.81% | 46.40% | 46.40% | 49.49% | 49.49% | 49.68% | 49.68% | |
| Interest Coverage (x)Derived | 9.51x | 9.51x | 1.25x | 1.25x | 33.97x | 33.97x | 357.59x | 357.59x | 33.48x | 33.48x | 1.50x | 1.50x | -0.16x | -0.16x |
CHEMFAB ALKALIS segment analysis : revenue and profit mix.
Disclosed business segments at CHEMFAB ALKALIS with their share of revenue and profit, switchable between consolidated and standalone reporting.
CHEMFAB ALKALIS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for CHEMFAB ALKALIS.
Our AI distills the core fundamental drivers supporting CHEMFAB ALKALIS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
CHEMFAB ALKALIS's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding stable at 25.1%, demonstrating founder commitment and governance alignment.
Conservative debt-to-equity ratio of 0.0033, indicating minimal financial leverage and lower risk.
Quarterly sales grew 19.60% YoY to ₹91.54 Cr, demonstrating solid near-term demand momentum.
Operating cash flow positive at ₹40.94 Cr (FY26), supporting dividend payments and operations.
Low price-to-book ratio of 1.37, suggesting reasonable valuation relative to tangible assets.
Key Risks.
TTM EPS declined to −9.17, reflecting severe profitability challenges and negative earnings.
Return on Equity of −0.91% and ROCE of 0.59% indicate critically poor capital efficiency.
Operating margin compressed to 2.41% (FY26) from 9.78% five-year average, signaling deterioration.
Latest quarterly profit variance −15.73% YoY shows extreme earnings volatility and unpredictability.
FII holdings negligible at 0.01%, signaling complete loss of institutional investor confidence.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Income thesis breaks if the dividend is cut or yield falls below 0.19%.
CHEMFAB ALKALIS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — CHEMFAB ALKALIS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
CHEMFAB ALKALIS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for CHEMFAB ALKALIS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
CHEMFAB ALKALIS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for CHEMFAB ALKALIS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in CHEMFAB ALKALIS stood at 68.7% of traded volume, against a 20-day average of 71.7%.
CHEMFAB ALKALIS announcements: results, concalls, ratings, M&A.
Filings CHEMFAB ALKALIS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
CHEMFAB ALKALIS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 70 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Chemfab Alkalis Limited has informed the Exchange about Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the…
Credit Rating
Chemfab Alkalis Limited has informed the Exchange about Credit Rating
Trading Window
Chemfab Alkalis Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,…
Shareholders meeting
Chemfab Alkalis Limited has informed the Exchange about voting results along with Scrutinizers Report of the Annual General Meeting held on 09th…
Change in Auditors
Chemfab Alkalis Limited has informed the Exchange regarding Change in Auditors of the company.
Investor decks & rating reports.
Updates
Updates
Updates
Updates
Updates
CHEMFAB ALKALIS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue CHEMFAB ALKALIS has declared, sequenced by announce and record date.
CHEMFAB ALKALIS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
CHEMFAB ALKALIS insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in CHEMFAB ALKALIS as reported to SEBI — buying and selling signals from the people who know the business best.
CHEMFAB ALKALIS insider activity below tracks 2 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| VAITHAMANITHI MUDUMBAI SRINIVASAN | Insider | 31 Jan 2025 | buy | +35.5 K | ₹34.73 L | ₹97.83 |
| S Prasath | Insider | 30 Jan 2025 | buy | +14.0 K | ₹13.7 L | ₹97.83 |
About CHEMFAB ALKALIS: business, sector, key facts.
What CHEMFAB ALKALIS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
CHEMFAB ALKALIS operates in the Commodity Chemicals industry under the Chemicals sector, listed as NSE: CHEMFAB, BSE: 541269.
Chemfab Alkalis Limited, along with its subsidiary Chemfab Alkalis Karaikal Limited, is a prominent Indian manufacturer and seller of inorganic chemicals with an international presence. Their primary business operations are divided into two segments: Chemicals and Related Products/Services, and PVC-O Pipes.
The Chemicals and Related Products/Services segment forms the core of Chemfab's business. This segment focuses on the production and distribution of a wide range of inorganic chemicals. Key products include caustic soda (in lye and flake forms), liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite (bleach liquor). Beyond these core offerings, they also manufacture sodium chlorate, aluminum chloride, and a diverse portfolio of other chemicals such as alkalis, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes, ketones, amines, alkaloids, potassium chlorate, and perchlorate, along with their by-products and derivatives. This breadth of offerings caters to a variety of industrial applications.
In addition to their extensive chemical portfolio, Chemfab Alkalis also operates in the PVC-O Pipes segment. This segment focuses on the manufacturing and sales of PVC-O (polyvinyl chloride-oriented) pipes, likely for industrial or commercial applications, though the specifics of target markets aren't provided in the source data. The company also produces industrial-grade and edible salt products, further diversifying its product offerings.
Founded in 1985 and initially known as Teamec Chlorates Limited, the company rebranded to Chemfab Alkalis Limited in July 2017. Headquartered in Chennai, India, Chemfab Alkalis has established itself as a significant player in the Indian and international inorganic chemical markets, leveraging its diverse product portfolio and manufacturing capabilities.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AMINES & PLASTICIZERS (AMNPLST) Share PricePeer
- ANDHRA SUGARS (ANDHRSUGAR) Share PricePeer
- CHEMPLAST SANMAR (CHEMPLASTS) Share PricePeer
- DEEPAK FERTILIZERS & PETR (DEEPAKFERT) Share PricePeer
- GHCL (GHCL) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about CHEMFAB ALKALIS (CHEMFAB).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of CHEMFAB ALKALIS (CHEMFAB)?
The current share price of CHEMFAB ALKALIS (CHEMFAB) is ₹332.30. Today, the stock has gained by ₹4.70 (1.43%), trading in a range of ₹316.80 to ₹351.80. The stock opened at ₹325.00 with a trading volume of 4,832 shares.
02Is CHEMFAB ALKALIS stock a good investment for long-term?
CHEMFAB ALKALIS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹475.77 Cr., P/E ratio of 0, ROE of -0.91%, and ROCE of 0.59%. The dividend yield stands at 0.38%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of CHEMFAB ALKALIS stock?
The 52-week high price of CHEMFAB ALKALIS (CHEMFAB) is ₹657.05, while the 52-week low is ₹290.35. Currently trading at ₹332.30, the stock is 14.45% above its 52-week low and 49.43% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy CHEMFAB ALKALIS stock at the current price?
Whether to buy CHEMFAB ALKALIS stock at ₹332.30 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 1.27. Today's performance shows a gain of 1.43%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of CHEMFAB ALKALIS and when is the next dividend?
CHEMFAB ALKALIS offers a dividend yield of 0.38%, which means for every ₹100 invested at the current price of ₹332.30, you can expect to receive approximately ₹0.38 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of CHEMFAB ALKALIS?
CHEMFAB ALKALIS's key financial metrics include: P/E Ratio: 0, P/B Ratio: 1.27, ROE: -0.91%, ROCE: 0.59%, Dividend Yield: 0.38%, EPS: ₹3.99, Book Value: ₹261.18, and Debt-to-Equity: 0.33. The company's market cap stands at ₹475.77 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is CHEMFAB ALKALIS stock performing today in the market?
CHEMFAB ALKALIS stock opened at ₹325.00 and is currently trading at ₹332.30, showing a gain of ₹4.70 (1.43%). The intraday high is ₹351.80 and low is ₹316.80. The trading volume stands at 4,832 shares, indicating moderate market participation today.
08What is the P/E ratio of CHEMFAB ALKALIS and what does it indicate?
CHEMFAB ALKALIS has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹3.99, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about CHEMFAB ALKALIS (CHEMFAB) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.